Medisanté and George Medicines bring Internet of Things (IoT) data collection to decentralised Phase III trial
Remote cellular-enabled blood pressure monitoring provides novel and secure way of collecting real world data (RWD) in decentralised global phase III pivotal study. Unique remote device monitoring (RDM) capabilities of Medisanté’s medical IoT platform (M+ Hub) enhance George Medicines’ clinical trial management system. Seamless decentralised data collection of blood pressure measurements over a secure private cellular …